In a recent published report, Kenneth Research has updated the market report for Interventional Oncology Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Interventional Oncology Market products.
Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10079041
According to a report by the World Health Organization (WHO), the total health spending is growing with an annual average rate of 6% in the low- and middle-income nations, and close to 4% in the high-income countries. Further, in the year 2016, the expenditure made on health reached close to 10% of the GDP of the world and crossed a value of USD 7 trillion.
Global Interventional Oncology Industry was valued at USD 2 Billion in the year 2019. Global Interventional Oncology Industry is further estimated to grow at a CAGR of 7.5% from 2019 to reach USD 3.28 Billion by the year 2025.
“Final Report will add the analysis of the impact of COVID-19 on this industry.”
The development of this market is principally determined by the rising inclination for negligibly intrusive techniques, extension of the objective patient populace, expanding open private subsidizing and government support for disease inquire about, mechanical progressions in the field of interventional oncology, and expanding government ventures and funding for interventional oncology and related cancer research.
The increasing demand for minimally invasive MI procedures is driving the growth of the global interventional oncology industry. The increasing awareness about the benefits of MI surgeries, such as reduced risk of shorter hospital stay, infection, minimal complications, lesser pain, and a faster recovery time when compared to the conventional open surgeries, are encouraging patients and surgeons to opt for MI surgeries, resulting in the high growth of this industry. The global interventional oncology industry will continue to be driven by these factors over the coming years.
The increasing demand of image-guided solutions in interventional oncology industry procedures, thanks to the improvement of these solutions provide in the treatment and diagnosis of cancer-related issues, is also expected to supplement the growth prospects of this industry in the near future.
Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10079041
In the presence of a number of local and international vendors characterizes the business landscape of the global industry for interventional oncology, which is highly competitive and diversified. Technological advancements and constant introduction of new products are likely to intensify the competitive environment in the industry. The leading market players are focusing on expanding their product portfolios.
Major market players in Interventional Oncology Industry are BTG plc , Medtronic, Boston Scientific, Terumo, Merit Medical, Sirtex, AngioDynamics, Ethicon, Teleflex , Cook Medical, HealthTronics, MedWaves Medical, Sanarus, IMBiotechnologies, Trod Medical, IceCure Medical, Mermaid Medicals, Interface Biomaterials BV, Guerbet, ABK Biomedical, Shape Memory Medical, Endo Shape, Monteris Medical, Instylla, and Trisalus Lifesciences.
Interventional Oncology Industry Segmentation:
Interventional Oncology Industry Overview, By Procedure
• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization
• Transcatheter Arterial Embolization
Interventional Oncology Industry Overview, By Cancer Type
• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers
Interventional Oncology Industry Overview, By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Request Free Sample Copy :-https://www.kennethresearch.com/sample-request-10079041
Table of Contents
1. Introduction
1.1 Industry Vision
1.2 Limitations
1.3 Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.2. Industry Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Turnover Process
2.3. Data Triangulation
2.4. Research Assumptions
2.4.1. Assumption
3. Executive Summary
4. Industry Overview
4.1. Introduction
4.2. Strength
4.3. Weakness
4.4. Opportunities
4.5. Threats
5. Industry Trends
5.1. Introduction
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Interventional Oncology Industry, By Procedure
6.1. Thermal Tumor Ablation
6.2. Non-Thermal Tumor Ablation
6.3. Transcatheter Arterial Chemoembolization
6.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
6.5. Transcatheter Arterial Embolization/Bland Embolization
7. Interventional Oncology Industry, By Cancer Type
7.1. Liver Cancer
7.2. Lung Cancer
7.3. Bone Cancer
7.4. Kidney Cancer
7.5. Other Cancers
8 Geographical Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. RoE
About Kenneth Research
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Contact Us
Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1-(347)-627-0064
————————New Latest Trending Reports——————————
Cranial Navigation Systems Market
Interventional Oncology Market
Molecular Diagnostics Industry Market
Medical alert system Market
IVD Market
Wearable Device Market
Endoscopy Equipment Market
Cancer Drug Market
Blood Screening Market
